Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon A Jones

Showing results (171-180 of 259) with videos related to

Pageof 26
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|September 28, 2010
Although IL-6 trans-signaling is sufficient to drive local immune responses, classical IL-6 signaling is obligate for the induction of T cell-mediated autoimmunityRami Lissilaa, Vanessa Buatois, Giovanni Magistrelli, et al.
Orphanet Journal of Rare Diseases|August 18, 2018
Annual severity increment score as a tool for stratifying patients with Niemann-Pick disease type C and for recruitment to clinical trialsMario Cortina-Borja, Danielle Te Vruchte, Eugen Mengel, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 21, 2020
Impaired Interleukin-27-Mediated Control of CD4+ T Cell Function Impact on Ectopic Lymphoid Structure Formation in Patients With Sjögren's SyndromeDavide Lucchesi, Rachel Coleby, Elena Pontarini, et al.
Journal of Neurology|August 13, 2021
Efficacy and safety of N-acetyl-L-leucine in Niemann-Pick disease type CTatiana Bremova-Ertl, Jens Claassen, Tomas Foltan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 2, 2012
Hematopoietic stem cell and gene therapy corrects primary neuropathology and behavior in mucopolysaccharidosis IIIA miceAlexander Langford-Smith, Fiona L Wilkinson, Kia J Langford-Smith, et al.
Orphanet Journal of Rare Diseases|October 9, 2015
Early treatment with laronidase improves clinical outcomes in patients with attenuated MPS I: a retrospective case series analysis of nine sibshipsNouriya A Al-Sannaa, Luisa Bay, Deborah S Barbouth, et al.
JIMD Reports|November 22, 2017
Cardiopulmonary Exercise Testing Reflects Improved Exercise Capacity in Response to Treatment in Morquio A Patients: Results of a 52-Week Pilot Study of Two Different Doses of Elosulfase AlfaKenneth I Berger, Barbara K Burton, Gregory D Lewis, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 26, 2008
Therapeutic targeting of IL-6 trans signaling counteracts STAT3 control of experimental inflammatory arthritisMari A Nowell, Anwen S Williams, Sarah A Carty, et al.
Blood|February 19, 2008
Circulating neutrophils maintain physiological blood pressure by suppressing bacteria and IFNgamma-dependent iNOS expression in the vasculature of healthy miceJonathan Morton, Barbara Coles, Kate Wright, et al.
Molecular Genetics and Metabolism Reports|October 23, 2025
Long-term neuromuscular, cardiac and liver outcomes in an adult man affected with Chanarin-Dorfman syndromeKinza Noman, Andreas Tridimas, James B Lilleker, et al.
Pageof 26

Showing results (171-180 of 259) with videos related to

Sort By:
Pageof 26
Journal of Immunology (Baltimore, Md. : 1950)|September 28, 2010
Although IL-6 trans-signaling is sufficient to drive local immune responses, classical IL-6 signaling is obligate for the induction of T cell-mediated autoimmunityRami Lissilaa, Vanessa Buatois, Giovanni Magistrelli, et al.
Orphanet Journal of Rare Diseases|August 18, 2018
Annual severity increment score as a tool for stratifying patients with Niemann-Pick disease type C and for recruitment to clinical trialsMario Cortina-Borja, Danielle Te Vruchte, Eugen Mengel, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 21, 2020
Impaired Interleukin-27-Mediated Control of CD4+ T Cell Function Impact on Ectopic Lymphoid Structure Formation in Patients With Sjögren's SyndromeDavide Lucchesi, Rachel Coleby, Elena Pontarini, et al.
Journal of Neurology|August 13, 2021
Efficacy and safety of N-acetyl-L-leucine in Niemann-Pick disease type CTatiana Bremova-Ertl, Jens Claassen, Tomas Foltan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 2, 2012
Hematopoietic stem cell and gene therapy corrects primary neuropathology and behavior in mucopolysaccharidosis IIIA miceAlexander Langford-Smith, Fiona L Wilkinson, Kia J Langford-Smith, et al.
Orphanet Journal of Rare Diseases|October 9, 2015
Early treatment with laronidase improves clinical outcomes in patients with attenuated MPS I: a retrospective case series analysis of nine sibshipsNouriya A Al-Sannaa, Luisa Bay, Deborah S Barbouth, et al.
JIMD Reports|November 22, 2017
Cardiopulmonary Exercise Testing Reflects Improved Exercise Capacity in Response to Treatment in Morquio A Patients: Results of a 52-Week Pilot Study of Two Different Doses of Elosulfase AlfaKenneth I Berger, Barbara K Burton, Gregory D Lewis, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 26, 2008
Therapeutic targeting of IL-6 trans signaling counteracts STAT3 control of experimental inflammatory arthritisMari A Nowell, Anwen S Williams, Sarah A Carty, et al.
Blood|February 19, 2008
Circulating neutrophils maintain physiological blood pressure by suppressing bacteria and IFNgamma-dependent iNOS expression in the vasculature of healthy miceJonathan Morton, Barbara Coles, Kate Wright, et al.
Molecular Genetics and Metabolism Reports|October 23, 2025
Long-term neuromuscular, cardiac and liver outcomes in an adult man affected with Chanarin-Dorfman syndromeKinza Noman, Andreas Tridimas, James B Lilleker, et al.
Pageof 26